Frazier Life Sciences宣布傅涛先生加入公司并担任创业合伙人。傅先生在制药和生物科技行业拥有超过25年的业务拓展、综合管理、运营、战略和商务领导经验。加入公司前,傅先生在生物科技公司再鼎医药(Zai Lab,已在纳斯达克(ZLAB)和香港公开上市)先后担任总裁兼首席运营官和首席战略官。任职期间,他曾负责该公司的多项业务,包括战略、运营、业务拓展,化学、生产与控制(CMC)、质控和...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.